What is Lucerno Dynamics?
Lucerno Dynamics is a specialized medical technology firm dedicated to the reduction of radiopharmaceutical extravasations. Its core offering, the Lara System, provides clinicians with real-time data and monitoring capabilities to identify and evaluate injection errors during nuclear medicine procedures. By integrating advanced diagnostic tools into the clinical workflow, the company addresses a critical gap in patient safety, ensuring that medical professionals can deliver high-quality care while minimizing the risks associated with radiopharmaceutical administration. The firm serves a vital role in the nuclear medicine ecosystem, where precision and safety are paramount to successful diagnostic outcomes.
How much funding has Lucerno Dynamics raised?
Lucerno Dynamics has raised a total of $11.1M across 5 funding rounds:
Multiple Rounds
$10.8M
Debt
$150K
Debt
$145K
Debt (2016): $950K, investors not publicly disclosed
Private Equity (2016): $3.5M, investors not publicly disclosed
Series A (2016): $6.3M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Debt (2021): $145K backed by PPP
Key Investors in Lucerno Dynamics
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Lucerno Dynamics?
With the recent influx of capital, Lucerno Dynamics is poised to transition into a more aggressive growth phase, focusing on the widespread adoption of the Lara System across major healthcare institutions. The strategic roadmap likely includes expanding the company's research and development efforts to refine its monitoring algorithms and potentially diversifying its product portfolio to address broader challenges in diagnostic imaging. As the company scales, it will likely focus on strengthening its market position through strategic partnerships with leading nuclear medicine departments, aiming to establish its technology as the gold standard for injection safety and procedural quality assurance in the global healthcare market.
See full Lucerno Dynamics company page
